[
    "{\"step_by_step_thinking\": \"Based on the information provided in the relevant documents, patient-controlled therapy (PCT) with opioids has been shown to be a feasible and acceptable therapeutic method to reduce refractory breathlessness in palliative care patients. Document [0] describes a pilot observational study where patients with advanced disease and refractory breathlessness received opioid PCT and experienced a decrease in breathlessness. Document [2] also mentions that optimum management of breathlessness in advanced cancer involves pharmacological treatment, primarily opioids. Therefore, based on the available evidence, the answer is yes, patient-controlled therapy of breathlessness in palliative care is a new therapeutic concept for opioid administration.\", \"answer_choice\": \"A\"}"
]